Holen Sie sich die Stockscreener-App
0.6507
6.08%
-0.0421
Schlusskurs vom Vortag:
$0.6928
Offen:
$0.6902
24-Stunden-Volumen:
82,276
Relative Volume:
0.03
Marktkapitalisierung:
$6.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.13M
KGV:
-1.4173
EPS:
-0.4591
Netto-Cashflow:
$-4.60M
1W Leistung:
-7.57%
1M Leistung:
-7.04%
6M Leistung:
-30.86%
1J Leistung:
-63.65%
1-Tages-Spanne:
$0.63
$0.6975
1-Wochen-Bereich:
$0.63
$0.75
52-Wochen-Spanne:
$0.63
$1.8199
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Firmenname
Pharmacyte Biotech Inc
Sektor
Branche
Telefon
(917) 595.2850
Adresse
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB vs PSNYW, SHMD, GOODO, DWLD, QQQE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
4.50 | 350.59M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.26 | 465.95M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.18 | 372.90M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
45.25 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
103.33 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Aktie (PMCB) Neueste Nachrichten
PMCB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Technical Analysis - Intellectia AI
PharmaCyte Biotech (PMCB) seeks reverse split and 2M share plan boost at virtual meeting - Stock Titan
Day Trade: Can PharmaCyte Biotech Inc keep up with sector leadersJuly 2025 Trends & Free Long-Term Investment Growth Plans - baoquankhu1.vn
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PharmaCyte Biotech delays quarterly report filing - MSN
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 5.9% Higher – Time to Buy? - Defense World
Volume Summary: What is SIM Acquisition Corp Is P E ratio telling usJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Is PharmaCyte Biotech Inc vulnerable to short sellersMarket Risk Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Is PharmaCyte Biotech Inc. trading at a discountWeekly Stock Report & Weekly High Momentum Picks - mfd.ru
Is PharmaCyte Biotech Inc. vulnerable to short sellersJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - bollywoodhelpline.com
Dividend Watch: Is PharmaCyte Biotech Inc in a bullish channelJuly 2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 4.3% – Time to Sell? - Defense World
Bull Run: Why PharmaCyte Biotech Inc stock attracts high net worth investorsInsider Selling & Weekly Breakout Watchlists - Bộ Nội Vụ
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
Hedge Fund and Insider Trading News: Paul Singer, Steve Cohen, Israel Englander, Ray Dalio, Rokos Capital Management, Viking Global, PharmaCyte Biotech Inc (PMCB), Cloudflare Inc (NET), and More - Insider Monkey
Why PharmaCyte Biotech Inc. stock could see breakout soonJuly 2025 Retail & Daily Growth Stock Tips - Улправда
Why PharmaCyte Biotech Inc. stock appeals to analystsJuly 2025 Outlook & Technical Entry and Exit Tips - Улправда
Will PharmaCyte Biotech Inc. stock rally after Fed decisionsWeekly Stock Report & Low Drawdown Trading Strategies - ulpravda.ru
How currency fluctuations impact PharmaCyte Biotech Inc. stockEarnings Summary Report & Long-Term Safe Investment Ideas - ulpravda.ru
Will PharmaCyte Biotech Inc. stock keep outperforming rivals2025 Sector Review & Risk Controlled Stock Alerts - Улправда
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria
PMCB Stock Insider Trading Activity - Quiver Quantitative
Pharmacyte Biotech CEO Silverman buys $80k in shares By Investing.com - Investing.com Nigeria
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 - Investing.com
Pharmacyte Biotech CEO Silverman buys $80k in shares - Investing.com
How institutional buying supports PharmaCyte Biotech Inc. stockEarnings Per Share Trends & Minimal Investment Trading Tips - ulpravda.ru
PharmaCyte Biotech (PMCB) Stock Analysis Report | Financials & Insights - Benzinga
Largest borrow rate increases among liquid names - TipRanks
Will PharmaCyte Biotech Inc. stock benefit from infrastructure spending2025 Top Gainers & Weekly Breakout Watchlists - Улправда
Is PharmaCyte Biotech Inc. stock positioned for digital transformation2025 Trading Recap & Free Community Supported Trade Ideas - Улправда
How PharmaCyte Biotech Inc. stock reacts to job market dataJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - Улправда
How sustainable is PharmaCyte Biotech Inc. stock dividend payoutVolume Spike & Weekly Momentum Stock Picks - Улправда
Why PharmaCyte Biotech Inc. stock is a value investor pickShare Buyback & Expert Verified Stock Movement Alerts - Улправда
PharmaCyte Biotech, Inc. SEC 10-Q Report - TradingView — Track All Markets
Movement Recap: How sustainable is PharmaCyte Biotech Inc. stock dividend payoutJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - Улправда
PharmaCyte Biotech Delays Quarterly Report Filing - TipRanks
PharmaCyte Biotech (PMCB) files notice of late Form 10-Q under Rule 12b-25 - Stock Titan
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):